-
EP2295974
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2295974
| EP2295974 - Compositions and methods for the detection of HIV-1/HIV-2 infection [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.10.2016 Database last updated on 21.05.2024 | Most recent event Tooltip | 28.10.2016 | Application deemed to be withdrawn | published on 30.11.2016 [2016/48] | Applicant(s) | For all designated states THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES The National Institute of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325 Rockville, MD 20852 / US | [2011/11] | Inventor(s) | 01 /
Golding, Hana 16532 Hillcroft Drive Rockville MD 20853 / US | 02 /
Khurana, Surender 797/5 Mohan Nagar Kurukshetra Haryana 132118 / IN | [2011/11] | Representative(s) | Rees, Kerry WP Thompson 138 Fetter Lane London EC4A 1BT / GB | [N/P] |
| Former [2014/30] | Rees, Kerry WP Thompson 55 Drury Lane London WC2B 5SQ / GB | ||
| Former [2011/11] | Ackroyd, Robert W.P. Thompson & Co. 55 Drury Lane London WC2B 5SQ / GB | Application number, filing date | 10174064.5 | 02.09.2005 | [2011/11] | Priority number, date | US20040607579P | 08.09.2004 Original published format: US 607579 P | US20050676931P | 03.05.2005 Original published format: US 676931 P | [2011/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2295974 | Date: | 16.03.2011 | Language: | EN | [2011/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.02.2011 | Classification | IPC: | G01N33/569, G01N33/538 | [2011/11] | CPC: |
G01N33/56988 (EP,US);
G01N33/6854 (US);
C07K14/005 (EP,US);
C07K14/161 (US);
C07K14/162 (US);
C07K14/163 (US);
C12N2740/16111 (US);
C12N2740/16122 (EP,US);
C12N2740/16222 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/11] | Title | German: | Zusammensetzungen und Verfahren zur Detektion von HIV-1/HIV-2 Infektion | [2011/11] | English: | Compositions and methods for the detection of HIV-1/HIV-2 infection | [2011/11] | French: | Compositions et procédés pour la détection d'une infection par VIH-1/VIH-2 | [2011/11] | Examination procedure | 25.08.2010 | Examination requested [2011/11] | 16.09.2011 | Amendment by applicant (claims and/or description) | 25.10.2012 | Despatch of a communication from the examining division (Time limit: M04) | 25.02.2013 | Reply to a communication from the examining division | 20.06.2013 | Despatch of a communication from the examining division (Time limit: M06) | 13.12.2013 | Reply to a communication from the examining division | 28.05.2014 | Despatch of a communication from the examining division (Time limit: M06) | 08.12.2014 | Reply to a communication from the examining division | 27.03.2015 | Despatch of a communication from the examining division (Time limit: M04) | 23.07.2015 | Reply to a communication from the examining division | 26.01.2016 | Despatch of a communication from the examining division (Time limit: M04) | 07.06.2016 | Application deemed to be withdrawn, date of legal effect [2016/48] | 04.07.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/48] | Parent application(s) Tooltip | EP05858397.2 / EP1800126 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050858397) is 17.03.2009 | Fees paid | Renewal fee | 25.08.2010 | Renewal fee patent year 03 | 25.08.2010 | Renewal fee patent year 04 | 25.08.2010 | Renewal fee patent year 05 | 25.08.2010 | Renewal fee patent year 06 | 26.09.2011 | Renewal fee patent year 07 | 25.09.2012 | Renewal fee patent year 08 | 27.09.2013 | Renewal fee patent year 09 | 29.09.2014 | Renewal fee patent year 10 | 28.09.2015 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US5260189 (FORMOSO CARL [US], et al) [A] 1-8* column 11, lines 21-49; claim 1 *; | [X]WO0154701 (AVENTIS PASTEUR S A [FR], et al) [X] 6 * page 12, lines 18-29 *; | [X] - GOMBERT F O ET AL, "ANTIGENIC EPITOPES OF NEF PROTEINS FROM DIFFERENT HIV-1 STRAINS AS RECOGNIZED BY SERA FROM PATIENTS WITH MANIFEST AND LATENT HIV INFECTION", VIROLOGY, (1990), vol. 176, no. 2, ISSN 0042-6822, pages 458 - 466, XP002450885 [X] 1-8 * page 465, paragraph L; figure 4 * | [X] - SCHNEIDER T ET AL, "EPITOPES OF THE HIV-1-NEGATIVE FACTOR NEF REACTIVE WITH MURINE MONOCLONAL ANTIBODIES AND HUMAN HIV-1-POSITIVE SERA", AIDS RESEARCH AND HUMAN RETROVIRUSES, (1991), vol. 7, no. 1, ISSN 0889-2229, pages 37 - 44, XP009089364 [X] 6-8 * page 41, column L, paragraph 1; figure 4 * | [X] - "HIV Nef-1 CTL epitope.", Geneseq, (20010925), Database accession no. AAB98916, URL: EBI, XP002451124 [X] 6-8 * abstract * | [A] - ALCARO MARIA CLAUDIA ET AL, "Synthetic peptides in the diagnosis of HIV infection.", CURRENT PROTEIN AND PEPTIDE SCIENCE, (200308), vol. 4, no. 4, ISSN 1389-2037, pages 285 - 290, XP009083035 [A] 1-8 * page 286, column R, paragraph 2 * DOI: http://dx.doi.org/10.2174/1389203033487117 | by applicant | US3791932 | US4016043 | US4185084 | US4243749 | US4313734 | GB2084317 | US4373932 | US4401764 | EP0177191 | US4661444 | US4746631 | WO9008162 | EP0439077 | US5260189 | US5459060 | US5462852 | US5476765 | US5501985 | US5563036 | US5599662 | US5627080 | US5633141 | US5637453 | US5660979 | US5679525 | US5681696 | US5691147 | US5695930 | US5698411 | US5705331 | US5712385 | US5721095 | US5747352 | US5759781 | US5811526 | US5830641 | US5849494 | US5851778 | US5856088 | US5876935 | US5891623 | US5925513 | US5928642 | US5976822 | US6004925 | US6008044 | US6048685 | EP0439077 | US6245737 | US6252059 | US6270959 | US6352826 | US6399307 | US6429289 | US6458527 | US6492104 | US6531276 | US6534285 | US6541609 | US6582920 | US6586177 | US6589734 | US6623920 | US6649749 | US6689879 | - VARMUS, H., "RjETROVIRUSES", SCIENCE, (1988), vol. 240, pages 1427 - 1439 | - COWLEY S., "THE BIOLOGY OF HIV INFECTION", LEPR REV., (2001), vol. 72, no. 2, pages 212 - 20 | - GALLO, R.C. ET AL., "Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)", SCIENCE, (1983), vol. 220, no. 4599, pages 865 - 7 | - BARRE-SINOUSSI, F. ET AL., "ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)", SCIENCE, (1983), vol. 220, pages 868 - 870 | - GALLO, R. ET AL., "FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETPOVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND ATRISK FOR AIDS", SCIENCE, (1984), vol. 224, pages 500 - 503 | - TEICH, N. ET AL, TEICH, N. ET AL, WEISS, R. ET AL., RNA TUMOR VIRUSES, COLD SPRING HARBOR PRESS, (1984), pages 949 - 956 | - ACKERS, M.L. ET AL., "HUMAN IMMUNODEFICIENCY VIRUS (HIV) SEROPOSITIVITY AMONG UNINFECTED HIV VACCINE RECIPIENTS", J INFECT DIS, (2003), vol. 187, pages 879 - 986 | - PITISUTTITHUM, P. ET AL., "SAFETY AND IMMUNOGENICITY OF COMBINATIONS OF RECOMBINANT SUBTYPE E AND B HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENVELOPE GLYCOPROTEIN 120 VACCINES IN HEALTHY THAI ADULTS", J INFECT DIS, (2003), vol. 188, pages 219 - 227 | - CHUENCHITRA, T. ET AL., "LONGITUDINAL STUDY OF HUMORAL IMMUNE RESPONSES IN HIV TYPE I SUBTYPE CRFO1 AE (E)-INFECTED THAI PATIENTS WITH DIFFERENT RATES OF DISEASE PROGRESSION", AIDS RES HUM RETROVIRUSES, (2003), vol. 19, pages 293 - 305 | - SCHWARTZ, D.H. ET AL., "UTILITY OF VARIOUS COMMERCIALLY AVAILABLE HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIBODY DIAGNOSTIC KITS FOR USE IN CONJUNCTION WITH EFFICACY TRIALS OF HIV-1 VACCINES", CLIN DIAGN LAB IMMUNOL, (1995), vol. 2, pages 268 - 271 | - BELSHE, R.B. ET AL., "INTERPRETING HIV SERODIAGNOSTIC TEST RESULTS IN THE 1990S: SOCIAL RISKS OF HIV VACCINE STUDIES IN UNINFECTED VOLUNTEERS", NIAID AIDS VACCINE CLINICAL TRIALS GROUP. ANN INTERN MED, (1994), vol. 121, pages 584 - 589 | - ALLEN, M. ET AL., TRIAL-RELATED DISCRIMINATION IN HIV VACCINE CLINICAL TRIALS. AIDS RES HUM RETROVIRUSES, (2001), vol. 17, pages 667 - 674 | - GROSS, M. ET AL., "INTEREST AMONG GAY/BISEXUAL MEN IN GREATER BOSTON IN PARTICIPATING IN CLINICAL TRIALS OF PREVENTIVE HIV VACCINES", J ACQUIR IMMUNE DEFIC SYNDR HUM RETROVIROL, (1996), vol. 12, pages 406 - 412 | - SHEON, A.R. ET AL., "PREVENTING DISCRIMINATION AGAINST VOLUNTEERS IN PROPHYLACTIC HIV VACCINE TRIALS: LESSONS FROM A PHASE II TRIAL", J ACQUIR IMMUNE DEFIC SYNDR HUM RETROVIROL, (1998), vol. 19, pages 519 - 526 | - KOBLIN, B.A. ET AL., "READINESS OF HIGH-RISK POPULATIONS IN THE HIV NETWORK FOR PREVENTION TRIALS To PARTICIPATE IN HIV VACCINE EFFICACY TRIALS IN THE UNITED STATES", AIDS, (1998), vol. 12, pages 785 - 793 | - SMITH, R.S. ET AL., "SYNTHETIC PEPTIDE ASSAYS TO DETECT HUMAN IMMUNODEFICIENCY VIRUS TYPES AND 2 IN SEROPOSITIVE INDIVIDUALS", ARCH PATHOL LAB MED., (1990), vol. 114, no. 3, pages 254 - 258 | - BAILLOU, A. ET AL., "FINE SEROTYPING OF HUMAN IMMUNODEFICIENCY VIRUS SEROTYPE I (HIV-I) AND HIV-2 INFECTIONS BY USING SYNTHETIC OLIGOPEPTIDES REPRESENTING AN IMMUNODOMINANT DOMAIN OF HIV-1 AND HIV-2/SIMIAN IMMUNODEFICIENCY VIRUS", J CLIN MICROBIOL., (1991), vol. 29, no. 7, pages 1387 - 1391 | - DALGLEISH, A. ET AL., "THE CD4 (T4) ANTIGEN Is AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS", NATURE, (1984), vol. 312, pages 767 - 768 | - MADDON ET AL., "THE T4 GENE ENCODES THE AIDS VIRUS RECEPTOR AND IS EXPRESSED IN THE IMMUNE SYSTEM AND THE BRAIN", CELL, (1986), vol. 47, pages 333 - 348 | - MCDOUGAL, J. S. ET AL., "BINDING OF HTLV-IIIILAV To T4+ T CELLS BY A COMPLEX OF THE 110K VIRAL PROTEIN AND THE T4 MOLECULE", SCIENCE, (1986), vol. 231, pages 382 - 385 | - MCGAUGHEY, G.B ET AL., "PROGRESS TOWARDS THE DEVELOPMENT OF A HIV- GP41-DIRECTED VACCINE", CURR HIV RES., (2004), vol. 2, no. 2, pages 193 - 204 | - CHAN, D.C. ET AL., "CORE STRUCTURE OF GP41 FROM THE HIV ENVELOPE GLYCOPROTEIN", CELL, (1997), vol. 89, no. 2, pages 263 - 273 | - MCGAUGHEY, G.B ET AL., "PROGRESS TOWARDS THE DEVELOPMENT OF A HIV-1 GP41-DIRECTED VACCINE", CURR HIV RES., (2004), vol. 2, no. 2, pages 193 - 204 | - CHAN, D.C. ET AL., "HIV ENTRY AND ITS INHIBITION", CELL, (1998), vol. 93, no. 5, pages 681 - 684 | - MANOCHA, M. ET AL., "COMPARING MODIFIED AND PLAIN PEPTIDE LINKED ENZYME IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-(HIV-I) AND TYPE-2 (HIV-2) ANTIBODIES", IMMUNOL LETT., (2003), vol. 85, no. 3, pages 275 - 278 | - MORTIMER, P.P., "THE FALLIBILITY OF HIV WESTERN BLOT", LANCET, (1991), vol. 11, pages 286 - 286 | - GNANN, J. W. JR. ET AL., "CUSTOM-DESIGNED SYNTHETIC PEPTIDE IMMUNOASSAYS FOR DISTINGUISHING HIV TYPE I AND TYPE 2 INFECTIONS", METHODS ENZYMOL., (1989), vol. 178, pages 693 - 714 | - BRATTEGAARD, K. ET AL., "INSENSITIVITY OF A SYNTHETIC PEPTIDE-BASED TEST (PEPTI-LAV 1-2) FOR THE DIAGNOSIS OF HIV INFECTION IN AFRICAN CHILDREN", AIDS, (1995), vol. 9, no. 6, pages 656 - 657 | - DöPEL, S.H. ET AL., "COMPARISON OF FOUR ANTI-HIV SCREENING ASSAYS WHICH BELONG TO DIFFERENT TEST GENERATIONS", EUR. J. CLIN. CHEM. CLIN. BIOCHEM., (1991), vol. 29, pages 331 - 337 | - MANOCHA, M. ET AL., "COMPARING MODIFIED AND PLAIN PEPTIDE LINKED ENZYME IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HtV-1) AND TYPE-2 (HIV-2) ANTIBODIES", IMMUNOL LETT., (2003), vol. 85, no. 3, pages 275 - 278 | - ALCARO, M.C. ET AL., "SYNTHETIC PEPTIDES IN THE DIAGNOSIS OF HIV INFECTION", CURR PROTEIN PEPT SCI., (2003), vol. 4, no. 4, pages 285 - 290 | - BERISTAIN, C.N. ET AL., "EVALUATION OF A DIPSTICK METHOD FOR THE DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION", CLIN. LAB. ANAL., (1995), vol. 9, no. 6, pages 347 - 350 | - DöPEL, S.H. ET AL., "COMPARISON OF FOUR ANTI-HIV SCREENING ASSAYS WIIICH BELONG TO DIFFERENT TEST GENERATIONS", EUR. J. CLIN. CHEM. CLIN. BIOCHEM., (1991), vol. 29, pages 331 - 337 | - MANOCHA, M. ET AL., "COMPARING MODIFIED AND PLAIN PEPTIDE LINKED ENZYME IMMUNOSORBENT ASSAY (ELI SA) FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) AND TYPE-2 (HIV-2) ANTIBODIES", IMMUNOL LETT., (2003), vol. 85, no. 3, pages 275 - 278 | - BAILLOU, A. ET AL., "FINE SEROTYPING OF HUMAN IMMUNODEFICIENCY VIRUS SEROTYPE 1 (HIV-1) AND HIV-2 INFECTIONS BY USING SYNTHETIC OLIGOPEPTIDES REPRESENTING AN IMMUNODOMINANT DOMAIN OF HIV- AND HIV-2/SIMIAN IMMUNODEFICIENCY VIRUS", J CLIN MICROBIAL., (1991), vol. 29, no. 7, pages 1387 - 1391 | - GNANN, J.W. JR. ET AL., "CUSTOM-DESIGNED SYNTHETIC PEPTIDE IMMUNOASSAYS FOR DISTINGUISHING HIV TYPE I AND TYPE 2 INFECTIONS", METHODS ENZYMOL., (1989), vol. 178, pages 693 - 714 | - BERISTAIN, C.N. ET AL., "EVALUATION OF A DIPSTICK METHOD FOR THE DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION", J CLIN LAB ANAL., (1995), vol. 9, no. 6, pages 347 - 350 | - MODROW, S. ET AL., "CARRIER BOUND SYNTHETIC OLIGOPEPTIDES IN ELISA TEST SYSTEMS FOR DISTINCTION BETWEEN HIV-1 AND HIV-2 INFECTION", J ACQUIR IMMUNE DEFIC SYNDR., (1989), vol. 2, no. 2, pages 141 - 148 | - SMITH, R.S. ET AL., "SYNTHETIC PEPTIDE ASSAYS TO DETECT HUMAN IMMUNODEFICIENCY VIRUS TYPES I AND 2 IN SEROPOSITIVE INDIVIDUALS", ARCH PATHOL LAB MED., (1990), vol. 14, no. 3, pages 254 - 258 | - MANOCHA, M. ET AL., "COMPARING MODIFIED AND PLAIN PEPTIDE LINKED ENZYME IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) AND TYPE-2 (HIV-2) ANTIBODIES", IMMUNOL LETT., (2003), vol. 85, no. 3, pages 275 - 278 | - PETROV, R.V. ET AL., "THE USE OF SYNTHETIC PEPTIDES IN THE DIAGNOSIS OF HIV INFECTIONS", BIOMED SCI., (1990), pages 239 - 244 | - DöPEL, S.H. ET AL., "FINE MAPPING OF AN IMMUNODOMINANT REGION OF THE TRANSMEMBRANE PROTEIN OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV-1)", J. VIROL. METH., (1990), vol. 25, pages 167 - 178 | - SMITH, R.S. ET AL., "SYNTHETIC PEPTIDE ASSAYS TO DETECT HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 IN SEROPOSITIVE INDIVIDUALS", ARCH PATHOL LAB MED., (1990), vol. 114, no. 3, pages 254 - 258 | - BAILLOU, A. ET AL., "FINE SEROTYPING OF HUMAN IMMUNODEFICIENCY VIRUS SEROTYPE 1 (HIV-1) AND HIV-2 INFECTIONS BY USING SYNTHETIC OLIGOPEPTIDES REPRESENTING AN IMMUNODOMINANT DOMAIN OF HIV-1 AND HIV-2/SIMIAN IMMUNODEFICIENCY VIRUS", J CLIN MICROBIOL., (1991), vol. 29, no. 7, pages 1387 - 1391 | - GUEYE-NDIAYE, A. ET AL., "COST-EFFECTIVE DIAGNOSIS OF HIV-I AND HIV-2 BY RECOMBINANT-EXPRESSED ENV PEPTIDE (566/996) DOT-BLOT ANALYSIS", AIDS, (1993), vol. 7, no. 4, pages 475 - 481 | - SOMMERFELT, M.A. ET AL., "NOVEL PEPTIDE-BASED NIV-1 IMMUNOTHERAPY", EXPERT OPIN BIOL THER., (2004), vol. 4, no. 3, pages 349 - 61 | - MCGAUGHEY, G.B ET AL., "PROGRESS TOWARDS THE DEVELOPMENT OF A HIV-1 GP41-DJRECTED VACCINE", CURR HIV RES., (2004), vol. 2, no. 2, pages 193 - 204 | - SOMMERFELT, M.A. ET AL., "NOVEL PEPTIDE-BASED HIV-1 IMMUNOTHERAPY", EXPERT OPIN BIOL THER., (2004), vol. 4, no. 3, pages 349 - 61 | - BERZOFSKY, J.A. ET AL., "NOVEL APPROACHES To PEPTIDE AND ENGINEERED PROTEIN VACCINES FOR HIV USING DEFINED EPITOPES: ADVANCES", AIDS, (1995), vol. 9, no. A, pages I43 - 157 | - CHOPPIN, J. ET AL., "CHARACTERISTICS OF HIV-I NEF REGIONS CONTAINING MULTIPLE CD8+ T CELL EPITOPES: WEALTH OF HLA-BINDING MOTIFS AND SENSITIVITY TO PROTEASOME DEGRADATION", J IMMUNOL., (2001), vol. J66, no. 10, pages 6164 - 6169 | - BERZOFSKY, J.A. ET AL., "APPROACHES To IMPROVE ENGINEERED VACCINES FOR HUMAN IMMUNODEFICIENCY VIRUS AND OTHER VIRUSES THAT CAUSE CHRONIC INFECFIONS", IMMUNOL REV., (1999), vol. 170, pages 15I - I 72 | - CHO, M.W., "SUBUNIT PROTEIN VACCINES: THEORETICAL AND PRACTICAL CONSIDERATIONS FOR HIV-l", CURR MOL MED., (2003), vol. 3, no. 3, pages 243 - 263 | - SABATIER, J.M. ET AL., "USE OF SYNTHETIC PEPTIDES FOR THE DETECTION OF ANTIBODIES AGAINST THE NEF REGULATING PROTEIN IN SERA OF HIV-INFECTED PATIENTS", AIDS, (1989), vol. 3, no. 4, pages 215 - 220 | - VAN DER RYST, E., "PROGRESS IN HIV VACCINE RESEARCH", ORAL DIS., (2002), vol. 8, no. 2, pages 21 - 26 | - ZOLLA-PAZNER, S., "IDENTIFYING EPITOPES OF HIV-1 THAT INDUCE PROTECTIVE ANTIBODIES", NAT REV IMMUNOL., (2004), vol. 4, no. 3, pages 199 - 210 | - PETROV, R.V. ET AL., "THE USE OF SYNTHETIC PEPTIDES IN THE DIAGNOSIS OF HIV INFECTIONS", BIOMED SCI., (1990), vol. 1, no. 3, pages 239 - 244 | - SOMMERFELT, M.A. ET AL., "NOVEL PEPTIDE-BASED HIV- IMMUNO'FHERAPY", EXPERT OPIN BIOL THER., (2004), vol. 4, no. 3, pages 349 - 61 | - FRANCIS, D.P. ET AL., "CANDIDATE HIV/AIDS VACCINES: LESSONS LEARNED FROM THE WORLD'S FIRST PHASE III EFFICACY TRIALS", AIDS, (2003), vol. 17, pages 147 - 56 | - GRAHAM, B.S. ET AL., "LESSONS FROM FAILURE--PREPARING FOR FUTURE HIV- VACCINE EFFICACY TRIALS", J INFECT DIS, (2005), vol. 191, pages 647 - 649 | - CHUENCHITRA, T. ET AL., "LONGITUDINAL STUDY OF HUMORAL IMMUNE RESPONSES IN HIV TYPE 1 SUBTYPE CRFO1 AE (E)-INFECTED THAI PATIENTS WITH DIFFERENT RATES OF DISEASE PROGRESSION", AIDS RES HUM RETROVIRUSES, (2003), vol. 19, pages 293 - 305 | - MARTA-LOUISE ACKERS ET AL., J. INFECT. DIS., (2003), vol. 187, page 879 | - COSTA, G.L. ET AL., "POLISHING WITH T4 OR PFU POLYMERASE INCREASES THE EFFICIENCY OF CLONING OF PCR FRAGMENTS", NUCLEIC ACIDS RES., (1994), vol. 22, no. 12, page 2423 | - FANG, H. ET AL., J. VIROL., (1995), vol. 69, no. 1, pages 75 - 81 | - WILLEY, R.L. ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1986), vol. 83, no. 14, pages 5038 - 5042 | - FANG, H. ET AL., J. VIROL., (1995), vol. 69, no. I, pages 75 - 81 | - RATNER, L. ET AL., NATURE, (1985), vol. 313, pages 277 - 284 | - MERRIFIELD, R B., "SOLID-PHASE PEPTIDE SYNTHESIS", ADV. ENZYMOL. RELAT AREAS MOL. BIOL., (1969), vol. 32, pages 221 - 296 | - FAIRWELL, T. ET AL., "HUMAN PLASMA APOLIPOPROTEIN C-II: TOTAL SOLID-PHASE SYNTHESIS AND CHEMICAL AND BIOLOGICAL CHARACTERIZATION", PROC. NATI. ACAD. SCI. U. S. A, (1987), vol. 84, pages 4796 - 4800 | - KENT, S.B.H., "CHEMICAL SYNTHESIS OF PEPTIDES AND PROTEINS", ANN. REV. BIOCHEM., (1988), vol. 57, pages 957 - 984 | - SCHNöLZER, M. ET AL., "CONSTRUCTING PROTEINS BY DOVETAILING UNPROTECTED SYNTHETIC PEPTIDES: BACKBONE-ENGINEERED HIV PROTEASE", SCIENCE, (19920410), vol. 256, no. 5054, pages 221 - 5 | - SCHNöLZER, M., "IN SITU NEUTRALIZATION IN BOC-CHEMISTRY SOLID PHASE PEPTIDE SYNTHESIS. RAPID, HIGH YIELD ASSEMBLY OF DIFFICULT SEQUENCES", INT JPEPT PROTEIN RES., (199209), vol. 40, no. 3-4, pages 180 - 193 | - ROSE ET AL., "STEPWISE SOLID-PHASE SYNTHESIS OF POLYAMIDES AS LINKERS", J. AM. CHEM. SOC., (19990804), vol. 121, pages 7034 - 7038 | - BRUTLAG ET AL., COMP. APP. BIOSCI., (1990), vol. 6, pages 237 - 245 | - GNANN, J.W. JR ET AL., "CUSTOM-DESIGNED SYNTHETIC PEPTIDE IMMUNOASSAYS FOR DISTINGUISHING HIV TYPE 1 AND TYPE 2 INFECTIONS", METHODS ENZYMOL., (1989), vol. 178, pages 693 - 714 | - DOPEL, S.H., "COMPARISON OF FOUR ANTI-HIV SCREENING ASSAYS WHICH BELONG To DIFFERENT TEST GENERATIONS", EUR J CLIN CHEM CLIN BIOCHEM., (199105), vol. 29, no. 5, pages 331 - 7 | - MANOCHA, M. ET AL., "COMPARING MODIFIED AND PLAIN PEPTIDE LINKED ENZYME IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) AND TYPE-2 (HIV-2) ANTIBODIES", IMMUNOL LETT., (20030203), vol. 85, no. 3, pages 275 - 8 | - BRATTEGAARD, K. ET AL., "INSENSITIVITY OF A SYNTHETIC PEPTIDE-BASED TEST (PEPTI-LAV 1-2) FOR THE DIAGNOSIS OF HIV INFECTION IN AFRICAN CHILDREN", AIDS, (199506), vol. 9, no. 6, pages 656 - 7 | - BERISTAIN, C.N. ET AL., "EVALUATION OF A DIPSTICK METHOD FOR THE DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION", J CLIN LAB ANAL., (1995), vol. 9, no. 6, pages 347 - 50 | - MODROW, S. ET AL., "CARRIER BOUND SYNTHETIC OLIGOPEPTIDES IN ELISA TEST SYSTEMS FOR DISTINCTION BETWEEN HIV-1 AND HIV-2 INFECTION", J ACQUIR IMMUNE DEFIC SYNDR., (1989), vol. 2, no. 2, pages 141 - 8 | - GUEYE-NDIAYE, A. ET AL., "CosT-EFFECTIVE DIAGNOSIS OF HIV- AND HIV-2 BY RECOMBINANT-EXPRESSED ENV PEPTIDE (566/996) DOT-BLOT ANALYSIS", AIDS, (199304), vol. 7, no. 4, pages 475 - 81 | - SABATIER, J.M. ET AL., "USE OF SYNTHETIC PEPTIDES FOR THE DETECTION OF ANTIBODIES AGAINST THE NEF REGULATING PROTEIN IN SERA OF HIV-INFECTED PATIENTS", AIDS, (198904), vol. 3, no. 4, pages 215 - 20 | - SOMMERFELT, M.A. ET AL., "NOVEL PEPTIDE-BASED HIV-1 IMMUNOTHERAPY", EXPERT OPIN BIOL THER., (200403), vol. 4, no. 3, pages 349 - 361 | - ALCARO, M.C. ET AL., "SYNTHETIC PEPTIDES IN THE DIAGNOSIS OF HIV INFECTION", CURR PROTEIN PEPT SCI., (200308), vol. 4, no. 4, pages 285 - 90 | - SMITH, R.S. ET AL., "SYNTHETIC PEPTIDE ASSAYS TO DETECT HUMAN IMMUNODEFICIENCY VIRUS TYPES 1 AND 2 IN SEROPOSITIVE INDIVIDUALS", ARCH PATHOL LAB MED., (199003), vol. 114, no. 3, pages 254 - 8 | - PETROV, R.V. ET AL., "THE USE OF SYNTHETIC PEPTIDES IN THE DIAGNOSIS OF HIV INFECTIONS", BIOMED SCI., (199003), vol. 1, no. 3, pages 239 - 44 | - ZOLLA-PAZNER S., "IDENTIFYING EPITOPES OF HIV-1 THAT INDUCE PROTECTIVE ANTIBODIES", NAT REV IMMUNOL., (200403), vol. 4, no. 3, pages 199 - 21 0 | - BAILLOU, A. ET AL., "FINE SEROTYPING OF HUMAN IMMUNODEFICIENCY VIRUS SEROTYPE 1 (HIV-1) AND HIV-2 INFECTIONS BY USING SYNTHETIC OLIGOPEPTIDES REPRESENTING AN IMMUNODOMINANT DOMAIN OF HIV-1 AND HIV-2/SIMIAN IMMUNODEFICIENCY VIRUS", J CLIN MICROBIOL., (199107), vol. 29, no. 7, pages 1387 - 91 | - MCGAUGHEY, G.B. ET AL., "PROGRESS TOWARDS THE DEVELOPMENT OF A HIV-1 GP41-DIRECTED VACCINE", CURR HIV RES., (200404), vol. 2, no. 2, pages 193 - 204 | - NAKANE, P.K. ET AL., "PEROXlDASE-LABELED ANTIBODY. A NEW METHOD OF CONJUGATION", J HISTOCHEM CYTOCHEM., (1974), vol. 22, pages 1084 - 90 | - ISHIKAWA, E. ET AL., "ENZYME-LABELING OF ANTIBODIES AND THEIR FRAGMENTS FOR ENZYME IMMUNOASSAY AND IMMUNOHISTOCHEMICAL STAINING", J IMMUNOASSAY., (1983), vol. 49, no. 3, pages 209 - 327 | - FRAHM, N. ET AL., "CONSISTENT CYTOTOXIC-T-LYMPHOCYTE TARGETING OF IMMUNODOMINANT REGIONS IN HUMAN IMMUNODEFICIENCY VIRUS ACROSS MULTIPLE ETHNCITIES", J VIROL, (2004), vol. 78, pages 2187 - 2200 | - LEE, D. ET AL., "BREAKTHROUGH INFECTIONS DURING PHASE I AND 2 PRIME-BOOST HIV-1 VACCINE TRIALS WITH CANARYPOX VECTORS (ALVAC) AND BOOSTER DOSE OF RECOMBINANT Gp120 OR GP1 60", J INFECT DIS, (2004), vol. 190, pages 903 - 907 | - GILBERT, P.B. ET AL., "CORRELATION BETWEEN IMMUNOLOGIC RESPONSES To A RECOMBINANT GLYCOPROTEIN 120 VACCINE AND INCIDENCE OF HIV-1 INFECTION IN A PHASE 3 HIV-1 PREVENTIVE VACCINE TRIAL", J INFECT DIS, (2005), vol. 191, pages 666 - 677 |